Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Esperion Therapeutics, Inc. (ESPR)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
6.31+0.13 (+2.10%)
At close: 04:00PM EDT
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Currency in USD

Valuation Measures4

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 0.65
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 326.77
52 Week Low 33.28
50-Day Moving Average 35.40
200-Day Moving Average 37.33

Share Statistics

Avg Vol (3 month) 31.4M
Avg Vol (10 day) 31.34M
Shares Outstanding 562.32M
Implied Shares Outstanding 6N/A
Float 851.56M
% Held by Insiders 10.97%
% Held by Institutions 196.34%
Shares Short (Apr 28, 2022) 48.78M
Short Ratio (Apr 28, 2022) 47.23
Short % of Float (Apr 28, 2022) 420.67%
Short % of Shares Outstanding (Apr 28, 2022) 414.37%
Shares Short (prior month Mar 30, 2022) 47.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:6
Last Split Date 3Jun 10, 2013

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Dec 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-272.13%

Management Effectiveness

Return on Assets (ttm)-36.31%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)78.45M
Revenue Per Share (ttm)2.71
Quarterly Revenue Growth (yoy)59.80%
Gross Profit (ttm)-41.74M
EBITDA -212.87M
Net Income Avi to Common (ttm)-269.11M
Diluted EPS (ttm)-11.69
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)259.33M
Total Cash Per Share (mrq)4.13
Total Debt (mrq)517.24M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)4.49
Book Value Per Share (mrq)-13.53

Cash Flow Statement

Operating Cash Flow (ttm)-263.81M
Levered Free Cash Flow (ttm)-192.19M
Advertisement
Advertisement